Addition of rosiglitazone is effective in patients with type 2 diabetes that is inadequately controlled

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1349, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus

By Tatti Patrizio

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 327-332

Adis International

Access to resources Recommend Favorite

Adjunctive rosiglitazone significantly improves glycaemic control in patients with type 2 diabetes

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

In Finland, repaglinide is dominant to nateglinide as combination therapy with metformin for the treatment of type 2 diabetes mellitus inadequately controlled with monotherapy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 507, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The sweet and sour RECORD of rosiglitazone for type 2 diabetes

Reactions Weekly, Vol. 1, Iss. 1155, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Sitagliptin tops rosiglitazone for type 2 diabetes

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite